Introduction: What is Sutimlimab?
Sutimlimab is a monoclonal antibody designed to target and inhibit the activity of the complement system, specifically the C1s protein. This innovative medication is primarily used in the treatment of certain autoimmune conditions, particularly those associated with hemolytic anemia. By modulating the immune response, Sutimlimab helps to reduce the destruction of red blood cells, thereby improving patient outcomes.
Best Hospital Near me Chennai